The History of Flibanserin: From Advancement to FDA Authorization

2 years later, in 2015, the FDA ultimately provided authorization for Flibanserin, marking it as the first medicine authorized to deal with HSDD in premenopausal females. Considering that its approval, Flibanserin has actually been a game-changer for females’s health, particularly in the area of sexual health and wellness. While Flibanserin may not have actually begun as a drug planned to deal with HSDD, its journey and eventual FDA authorization have had a substantial impact on women’s wellness.

Rather of treating anxiety, the company determined to discover Flibanserin’s potential to tackle HSDD. Flibanserin first looked for approval from the FDA in 2010. Two years later, pushhealth.com (image source) in 2015, the FDA ultimately approved authorization for Flibanserin, noting it as the initial medicine authorized to treat HSDD in premenopausal women. Since its approval, Flibanserin has actually been a game-changer for females’s health and wellness, specifically in the location of sex-related health. While Flibanserin might not have begun as a medication intended to treat HSDD, its trip and also ultimate FDA authorization have actually had a substantial impact on women’s health.